Artiva Biotherapeutics (ARTV) Interest & Investment Income (2023 - 2026)
Artiva Biotherapeutics (ARTV) posted quarterly Interest & Investment Income of $912000.0 for Q1 2026, down 51.07% year-over-year from $1.9 million in Q1 2025, and down 21.51% quarter-over-quarter from $1.2 million in Q4 2025.
Powered by 
Analysis
Artiva Biotherapeutics (ARTV) Interest & Investment Income (2023 - 2026) Analysis & Trends
Artiva Biotherapeutics (ARTV) has reported Interest & Investment Income for 4 consecutive years, with $912000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest & Investment Income fell 51.07% year-over-year to $912000.0; the TTM figure through Mar 2026 stood at $5.0 million (down 23.71% YoY), while the FY2025 annual figure was $6.0 million, up 11.4% from the prior year.
- Interest & Investment Income fell to $912000.0 in Q1 2026 per ARTV's latest filing, from $1.2 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $2.2 million in Q4 2024 and bottomed at $418000.0 in Q3 2023.
- Historically, Interest & Investment Income has averaged $1.1 million across 4 years, with a median of $1.0 million in 2025.
- Annual changes were most pronounced in 2024 — Interest & Investment Income soared 341.63% — and 2026, when it plunged 51.07%.
- Artiva Biotherapeutics' Interest & Investment Income stood at $583000.0 in 2023, then jumped by 273.41% to $2.2 million in 2024, then sank by 46.62% to $1.2 million in 2025, then fell by 21.51% to $912000.0 in 2026.
- Business Quant data shows ARTV's Interest & Investment Income at $912000.0 in Q1 2026, $1.2 million in Q4 2025, and $1.4 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Artiva Biotherapeutics | 441.23 Mn | 441.23 Mn | - | 1.89 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.89 Mn |
| Mar 31, 2026 | 912,000.00 |
| Dec 31, 2025 | 1.16 Mn |
| Sep 30, 2025 | 1.37 Mn |
| Jun 30, 2025 | 1.56 Mn |
| Mar 31, 2025 | 1.86 Mn |
| Dec 31, 2024 | 2.18 Mn |
| Sep 30, 2024 | 1.85 Mn |
| Jun 30, 2024 | 676,000.00 |
| Mar 31, 2024 | 650,000.00 |
| Dec 31, 2023 | 583,000.00 |
| Sep 30, 2023 | 418,000.00 |
| Jun 30, 2023 | 509,000.00 |